PTIXW Protagenic Therapeutics Inc

USD 0.02 0.01 130.263158
Icon

Protagenic Therapeutics Inc (PTIXW) Stock Analysis and Price Targets

COMMON STOCK | | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02

+0.01 (+130.26)%

N/A

5.40K

N/A

N/A

Icon

PTIXW

Protagenic Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 0.02
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 0.02

Protagenic Therapeutics Inc (PTIXW) Stock Forecast

N/A

Based on the Protagenic Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Protagenic Therapeutics Inc is not available over the next 12 months. Protagenic Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Protagenic Therapeutics Inc is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Protagenic Therapeutics Inc’s stock price was USD 0.02. Protagenic Therapeutics Inc’s stock price has changed by +75.00% over the past week, +75.00% over the past month and -65.00% over the last year.

No recent analyst target price found for Protagenic Therapeutics Inc
No recent average analyst rating found for Protagenic Therapeutics Inc

Company Overview Protagenic Therapeutics Inc

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated pe...Read More

http://www.protagenic.com

149 Fifth Avenue, New York, NY, United States, 10010

0

December

USD

USA

Adjusted Closing Price for Protagenic Therapeutics Inc (PTIXW)

Loading...

Unadjusted Closing Price for Protagenic Therapeutics Inc (PTIXW)

Loading...

Share Trading Volume for Protagenic Therapeutics Inc Shares

Loading...

Compare Performance of Protagenic Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PTIXW

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Protagenic Therapeutics Inc (Sector: )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CHKEL
Chesapeake Energy Corporation +6.35 (+11.10%) USD5.28B N/A N/A

ETFs Containing PTIXW

Symbol Name PTIXW's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Protagenic Therapeutics Inc (PTIXW) Stock

Stock Target Advisor's fundamental analysis for Protagenic Therapeutics Inc's stock is Neutral.

Unfortunately we do not have enough data on PTIXW's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PTIXW's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PTIXW's stock to indicate if its overvalued.

The last closing price of PTIXW's stock was USD 0.02.

Unfortunately we do not currently have any market capitalization data for PTIXW's stock.

Unfortunately we do not have enough analyst data on PTIXW's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Protagenic Therapeutics Inc's stock.

As per our most recent records Protagenic Therapeutics Inc has 0 Employees.

Protagenic Therapeutics Inc's registered address is 149 Fifth Avenue, New York, NY, United States, 10010. You can get more information about it from Protagenic Therapeutics Inc's website at http://www.protagenic.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...